Don’t miss out - Get your tickets early!
Join this FREE WEBINAR presented by Dr Philip Wolfson (USA), CEO at The Ketamine Research Foundation
Topic: The Magic of Ketamine-Assisted Psychotherapies.
This webinar will cover the following topics:
1) What constitutes assisted psychotherapy with a psychedelic medicine with a focus on ketamine
2) Working clinically with Ketamine-Assisted Psychotherapy (KAP)
3) Psycholytic and psychedelic ketamine administration
4) The nature of transformative ketamine experiences as meditative experiences.
5) The course and integration of KAP work.
Date: Wednesday 9 August 2023
Time: 12:55pm for 1:00pm start – 2:15pm (incl Q&A) (AEST)
The presentation WILL BEGIN AT 1:00pm.
Location: Online. A link will be emailed to you with the viewing details
Don’t miss out - Get your tickets early! https://events.humanitix.com/mind-medicine-australia-free-webinar-dr-philip-wolfson-usa-the-magic-of-ketamine-assisted-psychotherapies
More about medicinal psychedelic treatments:
Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.
The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.